Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Revenue 2009–2025
Gyre Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Gyre Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 22.5 M, a 2.09% increase year-over-year.
- Gyre Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 101.9 M, a 7.29% decrease year-over-year.
- Gyre Therapeutics Inc. annual revenue for 2025 was 116.6 M, a 10.24% increase from 2024.
- Gyre Therapeutics Inc. annual revenue for 2024 was 105.8 M, a 6.78% decrease from 2023.
- Gyre Therapeutics Inc. annual revenue for 2023 was 113.5 M, a 10.91% increase from 2022.
- Gyre Therapeutics Inc. annual revenue for 2022 was 102.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gyre Therapeutics Inc. Market Cap — FAQ
Gyre Therapeutics Inc. (GYRE) market cap over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GYRE's market cap history?
The chart and table above show Gyre Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.